Viking Therapeutics Engages Investors at Major Upcoming Conferences in 2026
Viking Therapeutics Engages Investors at Major Upcoming Conferences in 2026
Viking Therapeutics, Inc. (NASDAQ: VKTX), a prominent player in the biopharmaceutical sphere, will be taking part in several significant investor conferences this March. The company is at the forefront of developing innovative therapeutic solutions targeting metabolic and endocrine disorders, and these conferences offer a prime opportunity to showcase its advancements.
Conference Participation Overview
Viking Therapeutics will present at the following investor events:
- - Leerink Partners Global Healthcare Conference 2026
Format: Fireside chat and one-on-one meetings
Fireside Chat Timing: 10:40 – 11:10 a.m. Eastern, March 10, 2026
Location: Miami, FL
- - 2026 Jefferies Biotech on the Beach Summit
Format: One-on-one meetings
Location: Miami, FL
A live broadcast of the Leerink presentation will be available via the Viking Therapeutics website, ensuring that interested parties can tune in. The company encourages those who miss the live session to check back later, as a replay will be accessible post-conference.
About Viking Therapeutics
Founded with a strong commitment to tackling metabolic and endocrine disorders, Viking Therapeutics leverages cutting-edge research to develop first-in-class therapies. Their portfolio includes:
- - VK2735: A dual agonist targeting the GLP-1 and GIP receptors. Currently, it's in Phase 3 trials focusing on obesity, showing promise in earlier trials regarding safety and clinical benefit.
- - VK2809: An oral small molecule selective thyroid hormone receptor beta agonist, aimed at treating lipid and metabolic disorders, has shown strong results in its Phase 2b trial for NASH.
- - VK0214: A candidate for treating X-linked adrenoleukodystrophy, which has demonstrated safety and efficacy in initial trials.
These advancements align with Viking's mission to improve the lives of patients grappling with complex health issues. The presentations at the upcoming conferences will provide insight into the company's ongoing projects, clinical trials, and future directions.
Why Attend?
Investors keen on biotechnology will find valuable insights during these events. Viking's management team is expected to share updates on their clinical programs, discuss the potential of their pipeline drugs, and elaborate on the company's strategic vision moving forward. Given the rapid advancements in the biotech sector, this is an unmissable opportunity for those interested in the evolving landscape of therapeutic solutions.
Further Information
Individuals seeking additional details about Viking Therapeutics and its innovative approaches can visit their official website at www.vikingtherapeutics.com. Here, interested parties can also access investor resources and get updates on forthcoming events.
With its participation in these high-profile conferences, Viking Therapeutics is poised to strengthen its relationships with investors and clarify its commitment to developing novel therapies that address pressing medical challenges in metabolism and endocrinology.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.